Whole-Body [(18)F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic Disease

The 2-deoxy-d-[(18)F]fluoro-D-glucose (FDG) positron emission tomography/computed tomography (PET/CT) is widely utilized to assess the vascular and articular inflammatory burden of patients with a suspected diagnosis of rheumatic disease. We aimed to elucidate the impact of [(18)F]FDG PET/CT on chan...

Descripción completa

Detalles Bibliográficos
Autores principales: Fröhlich, Matthias, Serfling, Sebastian, Higuchi, Takahiro, Pomper, Martin G., Rowe, Steven P., Schmalzing, Marc, Tony, Hans-Peter, Gernert, Michael, Strunz, Patrick-Pascal, Portegys, Jan, Schwaneck, Eva-Christina, Gadeholt, Ottar, Weich, Alexander, Buck, Andreas K., Bley, Thorsten A., Guggenberger, Konstanze V., Werner, Rudolf A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625716/
https://www.ncbi.nlm.nih.gov/pubmed/34829421
http://dx.doi.org/10.3390/diagnostics11112073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625716/
https://www.ncbi.nlm.nih.gov/pubmed/34829421
http://dx.doi.org/10.3390/diagnostics11112073

Ejemplares similares